NCT06756971

Brief Summary

Adenotonsillar hypertrophy is the most common reason for children to have sleep disordered breathing (SDB). Even though adenotonsillectomy improves sleep apnea in children, 20-40% of children will still have persistent SDB. Drug Induced Sleep Endoscopy (DISE) is a tool that dynamically evaluates the upper airway during simulated sleep. It identifies sites of upper airway obstruction and/or collapse. It is used to predict which children will get better if their tonsils and adenoids are removed, and which children have other reasons for SDB. DISE is done during a state of simulated sleep. Different anesthetic medications are currently being used. However, there is no identified ideal anesthetic medication to simulate natural sleep. Propofol and Dexmedetomidine are the most frequently used, either alone or in combination with other medications. The aim is to perform a head-to-head study comparing those 2 commonly used regimens. The investigator would like to learn how the anesthetic medication affects performing the procedure and how well our patients tolerate it. This helps us identify an ideal regimen that can be a standardized DISE protocol in the pediatric population in the future. Our objective is to determine which anesthetic regimen, Dexmedetomidine or Propofol, is safer and more efficacious. This will be a randomized controlled trial at the University of Iowa Stead Family Children's Hospital. Children with sleep disordered breathing will undergo DISE and subsequent surgical procedure based on the level of obstruction found during DISE. Via randomization the child will be preselected to have a specific anesthetic for the procedure, either Dexmedetomidine or Propofol. The investigator will record information related to the medications used, the vital signs, the ability to perform DISE fully, the findings seen on DISE and the surgery performed. Consent will be obtained from the legal guardian or parent with legal authority to consent.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jun 2022

Shorter than P25 for phase_2

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 21, 2022

Completed
11 days until next milestone

Study Start

First participant enrolled

June 1, 2022

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2023

Completed
1.2 years until next milestone

First Posted

Study publicly available on registry

January 3, 2025

Completed
Last Updated

January 3, 2025

Status Verified

January 1, 2025

Enrollment Period

1.4 years

First QC Date

May 21, 2022

Last Update Submit

January 2, 2025

Conditions

Keywords

Drug induced sleep endoscopysleep disordered breathingDISE directed surgerychildren

Outcome Measures

Primary Outcomes (1)

  • Comparing Dexmedetomidine and Propofol for successful DISE (Drug Induced Sleep Endoscopy) procedure in-terms regarding which drug works better without causing side effects

    5-20 minutes

Study Arms (2)

Propofol

ACTIVE COMPARATOR

Arm 1: Propofol 1. PO Versed (Benzodiazepine) preoperatively 2. Obtain baseline bispectral index (BIS) monitor 3. Mask induction with Sevoflurane 4. Intravenous access 5. Propofol bolus 0.5-2 mg/kg to start followed by infusion 200-350 mcg/kg/min 6. Wait around 2 minutes 7. BIS monitor with Propofol on board

Drug: Propofol

Dexmedetomidine

ACTIVE COMPARATOR

Arm 2: Dexmedetomidine 1. PO Versed (Benzodiazepine) preoperatively 2. Obtain baseline BIS monitor 3. Mask induction with Sevoflurane 4. Intravenous access 5. Dexmedetomidine bolus 0.5-3 mcg/kg to start followed by infusion 0.5-2mcg/kg/hr 6. Wait around 10 mins 7. BIS monitor with Dexmedetomidine on board

Drug: Dexmedetomidine

Interventions

Propofol will be administered until the patients is in an optimal plane that mimics natural sleep while spontaneously breathing to allow for a DISE evaluation

Also known as: Diprivan, Fresenius Propoven, Propofol-Lipuro, Propofol-II [DSC], TEVA-Propofol
Propofol

Dexmedetomidine will be administered until the patients is in an optimal plane that mimics natural sleep while spontaneously breathing to allow for a DISE evaluation

Also known as: Precedex
Dexmedetomidine

Eligibility Criteria

Age1 Month - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Children 1 month-18 years of age
  • Clinical diagnosis of sleep disordered breathing (SDB) either based on a Pediatric sleep questionnaire (\>33% on modified Pediatric Sleep Questionnaire (PSQ)) or Sleep study
  • Subject is deemed a surgical candidate for undergoing DISE, adenotonsillectomy or DISE directed surgery

You may not qualify if:

  • Adult patients
  • Hypersensitivity to propofol or dexmedetomidine or any of their components,
  • Allergies to eggs, egg products, soybeans, or soy products,
  • Congenital cardiac disease, cardiac conduction system pathology, and increased pulmonary artery pressure or decreased cardiac output (e.g., right-sided heart failure, septic shock).
  • Children who are receiving medicines with rate-slowing action on the atrioventricular node (eg, digoxin, nifedipine)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (6)

  • Friedman NR, Parikh SR, Ishman SL, Ruiz AG, El-Hakim H, Ulualp SO, Wootten CT, Koltai PJ, Chan DK. The current state of pediatric drug-induced sleep endoscopy. Laryngoscope. 2017 Jan;127(1):266-272. doi: 10.1002/lary.26091. Epub 2016 Jun 16.

    PMID: 27311407BACKGROUND
  • Liu KA, Liu CC, Alex G, Szmuk P, Mitchell RB. Anesthetic management of children undergoing drug-induced sleep endoscopy: A retrospective review. Int J Pediatr Otorhinolaryngol. 2020 Dec;139:110440. doi: 10.1016/j.ijporl.2020.110440. Epub 2020 Oct 14.

    PMID: 33080472BACKGROUND
  • Zhao LL, Liu H, Zhang YY, Wei JQ, Han Y, Han L, Yang JP. A Comparative Study on Efficacy and Safety of Propofol versus Dexmedetomidine in Sleep Apnea Patients undergoing Drug-Induced Sleep Endoscopy: A CONSORT-Prospective, Randomized, Controlled Clinical Trial. Biomed Res Int. 2018 Nov 1;2018:8696510. doi: 10.1155/2018/8696510. eCollection 2018.

    PMID: 30515416BACKGROUND
  • Kandil A, Subramanyam R, Hossain MM, Ishman S, Shott S, Tewari A, Mahmoud M. Comparison of the combination of dexmedetomidine and ketamine to propofol or propofol/sevoflurane for drug-induced sleep endoscopy in children. Paediatr Anaesth. 2016 Jul;26(7):742-51. doi: 10.1111/pan.12931. Epub 2016 May 23.

    PMID: 27212000BACKGROUND
  • Gazzaz MJ, Isaac A, Anderson S, Alsufyani N, Alrajhi Y, El-Hakim H. Does drug-induced sleep endoscopy change the surgical decision in surgically naive non-syndromic children with snoring/sleep disordered breathing from the standard adenotonsillectomy? A retrospective cohort study. J Otolaryngol Head Neck Surg. 2017 Feb 13;46(1):12. doi: 10.1186/s40463-017-0190-6.

    PMID: 28193298BACKGROUND
  • Baldassari CM, Lam DJ, Ishman SL, Chernobilsky B, Friedman NR, Giordano T, Lawlor C, Mitchell RB, Nardone H, Ruda J, Zalzal H, Deneal A, Dhepyasuwan N, Rosenfeld RM. Expert Consensus Statement: Pediatric Drug-Induced Sleep Endoscopy. Otolaryngol Head Neck Surg. 2021 Oct;165(4):578-591. doi: 10.1177/0194599820985000. Epub 2021 Jan 5.

    PMID: 33400611BACKGROUND

MeSH Terms

Conditions

Sleep Apnea Syndromes

Interventions

PropofolDexmedetomidine

Condition Hierarchy (Ancestors)

ApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsImidazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Officials

  • Sohit Kanotra, MD

    University of Iowa

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Once consent is obtained, the patient will be recruited. Name and surgical date will be provided to our statistician. Permuted block randomization will be performed. The patient will either receive Propofol or Dexmedetomidine as the anesthetic regimen intraoperatively. This will be delivered by the anesthesia team. The surgeon will be blinded, so as the patient. The anesthetist will not be blinded. DISE, adenotonsillectomy or DISE directed surgery will be performed. Data will be collected by the research team throughout the procedure and post procedure. This project does not involve the evaluation, or testing, of the safety and/or efficacy of a medical device or a new drug. This is an interventional study, in which the investigators are randomly assigning subjects to one of the two anesthetics, Propofol or Dexmedetomidine. All patients will have cardiopulmonary monitoring, and intravenous access.
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: This study will randomize n=120 study participants undergoing DISE to one of two anesthetic agents, Propofol or Dexmedetomidine. With equal allocation to each arm (n=60 per group).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 21, 2022

First Posted

January 3, 2025

Study Start

June 1, 2022

Primary Completion

November 1, 2023

Study Completion

November 1, 2023

Last Updated

January 3, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share